RiverNorth/DoubleLine Strategic Opportunity Fund, Inc. (OPP)
Live price chart, market sentiment, and community perspectives for RiverNorth/DoubleLine Strategic Opportunity Fund, Inc. (NYSE: OPP).
Live price chart, market sentiment, and community perspectives for RiverNorth/DoubleLine Strategic Opportunity Fund, Inc. (NYSE: OPP).
On our desk, OPP is viewed primarily through the lens of its yield and structural discount. With a recent share price around $7.71 to $7.73 and a net asset value hovering near $8.28 to $8.37, the discount to NAV sits roughly between -6.7% and -7.9%. Market participants are weighing the enticing 14.16% distribution rate against a hefty 37.25% total leverage ratio and a 2.94% expense ratio. While the dual-manager approach combining RiverNorth and DoubleLine offers tactical credit exposure, sentiment remains neutral-to-cautious as quantitative models flag mid-channel oscillations and neutral multi-horizon outlooks.
From a risk management standpoint, closed-end funds like OPP require careful evaluation of their underlying asset allocation and structural costs. The fund features a heavy concentration in bonds—totaling over 120% via its asset allocation metrics—alongside a negative cash positioning of roughly -23%, underscoring its leveraged nature. Weiss Ratings categorizes the fund with a 'Sell' recommendation, citing a Weak reward score paired with a Fair risk rating. Traders need to account for the 82% turnover ratio and the inherent volatility tied to mortgage-backed securities and tactical closed-end fund strategies.
When evaluating OPP for quantitative strategies or systematic setups, our quant desk highlights the lack of clear directional price positioning in certain timeframes alongside neutral sentiment across all horizons. Predictive AI models point toward a wait-and-see approach, noting mid-channel oscillation patterns. Analysts reviewing the setup should carefully track key quantitative signals around the $7.16 to $7.72 range, factoring in the ex-dividend timing and the historical Z-statistic of -0.03 for the 1-year ex-par metric.
Explore plasma cleansing, somatic organ swaps, and BCI.